Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Go back to Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results
(NASDAQ: AVIR) Delayed: 5.43 +0.10 (1.88%)
Previous Close $5.33    52 Week High $2.00 
Open $5.36    52 Week Low $1.15 
Day High $5.52    P/E N/A 
Day Low $5.33    EPS $0.00 
Volume 440,095